Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Institute for Hematopathology Hamburg, Hamburg, Germany.
PLoS One. 2022 Jul 18;17(7):e0271541. doi: 10.1371/journal.pone.0271541. eCollection 2022.
Asplenia or functional hyposplenism are risk factors for severe infections, and vaccinations against encapsulated bacteria are advised. There are only limited data regarding the spleen function of cirrhotic patients.
We evaluated spleen function in patients with liver cirrhosis, who were prospectively enrolled in this study. Spleen function was evaluated by the measurement of pitted erythrocytes. Functional hyposplenism was defined as a percentage of PE of >15%.
117 patients, mean age 58.4 years and 61.5% (n = 72) male with liver cirrhosis were included. Functional hyposplenism was diagnosed in 28/117 patients (23.9%). Pitted erythrocytes correlated with albumin (p = 0.024), bilirubin (p<0.001), international normalized ratio (INR; p = 0.004), model of end-stage liver disease (MELD) score (p<0.001) and liver stiffness (p = 0.011). Patients with functional hyposplenism had higher MELD scores (median 13 vs. 10; p = 0.021), liver stiffness (46.4 kPa vs. 26.3 kPa; p = 0.011), INR (1.3 vs. 1.2; p = 0.008) and a higher Child-Pugh stage (Child C in 32.1% vs. 11.2%; p = 0.019) as compared to patients without functional hyposplenism. Functional hyposplenism was not associated with the etiology of cirrhosis. Importantly, 9/19 patients with Child C cirrhosis had functional hyposplenism.
A quarter of patients with liver cirrhosis and almost 50% of patients with Child C cirrhosis have functional hyposplenism. Functional hyposplenism is associated with poor liver function and the degree of portal hypertension, which is characterized by higher liver stiffness measurements in transient elastography.
无脾或功能性脾功能减退是严重感染的危险因素,建议接种针对荚膜细菌的疫苗。关于肝硬化患者的脾脏功能,仅有有限的数据。
我们评估了前瞻性纳入本研究的肝硬化患者的脾脏功能。通过测量陷窝红细胞来评估脾脏功能。功能性脾功能减退定义为 PE%>15%。
共纳入 117 例平均年龄为 58.4 岁的肝硬化患者(61.5%为男性,n=72)。诊断功能性脾功能减退症 28 例(23.9%)。陷窝红细胞与白蛋白(p=0.024)、胆红素(p<0.001)、国际标准化比值(INR;p=0.004)、终末期肝病模型评分(MELD;p<0.001)和肝脏硬度(p=0.011)相关。功能性脾功能减退症患者的 MELD 评分较高(中位数 13 分比 10 分;p=0.021)、肝脏硬度较大(46.4kPa 比 26.3kPa;p=0.011)、INR 较高(1.3 比 1.2;p=0.008)和更高的 Child-Pugh 分期(Child C 期占 32.1%比 11.2%;p=0.019)。功能性脾功能减退症与肝硬化病因无关。重要的是,19 例 Child C 期肝硬化患者中有 9 例存在功能性脾功能减退症。
四分之一的肝硬化患者和近 50%的 Child C 期肝硬化患者存在功能性脾功能减退症。功能性脾功能减退症与肝功能和门静脉高压程度有关,这表现为瞬时弹性成像中肝脏硬度测量值较高。